Quantification of hepatitis B virus (HBV) DNA with a TaqMan HBV analyte-specific reagent following sample processing with the MagNA pure LC instrument

Journal of Clinical Microbiology

Volumn 44, Issue 4, 2006, Pages 1490-1494

  Germer, Jeffrey J ^a   Qutub, Mohammed O ^b   Mandrekar, Jayawant N ^a   Mitchell, P Shawn ^a   Yao, Joseph D C ^a  

^a MAYO CLINIC   (United States)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANALYTIC METHOD; ANTIBODY TITER; ARTICLE; AUTOMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA ISOLATION; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARD; VIRUS DETECTION; VIRUS LOAD;

DNA, VIRAL; HEPATITIS B VIRUS; HUMANS; INDICATORS AND REAGENTS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM; TAQ POLYMERASE; VIROLOGY;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 33645921308     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.4.1490-1494.2006     Document Type: Article

References (16)

1. Barbeau, J. M., J. Goforth, A. M. Caliendo, and F. S. Nolte. 2004. Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent. J. Clin. Microbiol. 42:3739-3746.
2. Beasley, R. P. 1988. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
3. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
4. Boom, R., C. J. Sol, R. Heijtink, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1991. Rapid purification of hepatitis B virus DNA from serum. J. Clin. Microbiol. 29:1804-1811.
5. Finney, D. J. 1971. Probit analysis, 3rd ed. Cambridge University Press, Cambridge, United Kingdom.
6. Germer, J. J., W. S. Harmsen, J. N. Mandrekar, P. S. Mitchell, and J. D. C. Yao. 2005. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA Pure LC instrument. J. Clin. Microbiol. 43:293-298.
7. Lee, W. M. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733-1745.
8. Lok, A. S., E. J. Heathcote, and J. H. Hoofnagle. 2001. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120:1828-1853.
9. Martinot-Peignoux, M., N. Boyer, M. Colombat, R. Akremi, B. N. Pham, S. Ollivier, C. Castelnau, D. Valla, C. Degott, and P. Marcellin. 2002. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J. Hepatol. 36:543-546.
10. Mommeja-Marin, H., E. Mondou, M. R. Blum, and F. Rousseau. 2003. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37:1309-1319.
11. Pawlotsky, J. M. 2003. Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J. Hepatol. 39(Suppl. 1):S31-S35.
12. Puchhammer-Stockl, E., C. W. Mandl, J. Kletzmayr, H. Holzmann, A. Hofmann, S. W. Aberle, F. X. Heinz, B. Watschinger, and H. Hofmann. 2000. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J. Infect. Dis. 181:2063-2066.
13. Saito, T., H. Shinzawa, T. Uchida, O. Kawamata, S. Honma, H. Watanabe, L. Shao, K. Saito, H. Togashi, and T. Takahashi. 1999. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J. Med. Virol. 58:325-331.
14. Weiss, J., H. Wu, B. Farrenkopf, T. Schultz, G. Song, S. Shah, and J. Siegel. 2004. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J. Clin. Virol. 30:86-93.
15. Yao, J. D., M. G. Beld, L. L. Oon, C. H. Sherlock, J. Germer, S. Menting, S. Y. Se Thoe, L. Merrick, R. Ziermann, J. Surtihadi, and H. J. Hnatyszyn. 2004. Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J. Clin. Microbiol. 42:800-806.
16. Yu, M. W., S. H. Yeh, P. J. Chen, Y. F. Liaw, C. L. Lin, C. J. Liu, W. L. Shih, J. H. Kao, D. S. Chen, and C. J. Chen. 2005. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J. Natl. Cancer Inst. 97:265-272.